Funding arb · Price arb / RWA
| Leg | Exchange | Price | Fund. /8h | Each payment | Next in | OI | Vol 24h | Lev | |
|---|---|---|---|---|---|---|---|---|---|
| LONG | 138.76 | +0.0048 | pay 0.0006% / 1h | 2m 33s | $359K | $172K | 20x | Long Popdex | |
| SHORT | 137.83 | +0.0033 | get 0.0004% / 1h | 2m 33s | $27K | $101K | 10x | Short Injective |
Price gap−0.670%46s
Funding gap−0.0015% /8h
Both sides work against this direction now: funding costs $0 a day on $10k and the gap is 0.822% under its 7d average. Swap the legs.
The two prices were read 46 s apart: part of this gap may be the market moving.
If you open now and hold
on $10k a leg · figures of the last 7D, not a forecastFunding−$5−0.0015% /8h now · paid −0.050% over the last 6 days (all we have)
Price—spread −0.670%46s now · prices read too far apart to compare
Costsdoesn’t fit$10k a leg is deeper than the books hold
Result, before costs—no pointsneeds both prices read together
Funding history
you earnyou payavg
RANGE STATS · 7D
Average /8h—
Highest—
Lowest—
Paid you—
Short leg rate minus long leg rate, per 8h. Above zero: the pair pays you.
Price spread between the two exchanges
Injective price against Popdexnow
RANGE STATS · 7D
Now−0.670%
Average—
Range—
Wider than now—
Where the spread has been, last 7D▾
share of time at each level
Funding on every exchange
/8hORCL on 29 exchanges
lowest funding firstBefore you open
2 ok · 3 to watch- Problem: Doesn’t fit the books—$10k a leg is deeper than Injective’s order book right now.
- Note: Margin at max leverage$500 + $1,000Popdex 20x, Injective 10x. Keep about 2× this so a sharp move doesn’t liquidate one leg.
- OK: Same payment interval1h / 1hBoth legs pay at the same time.Next 24h at the current rates, on $10k a leg: −$0.44Long Popdex: 24 payments, −$1.44; short Injective: 24 payments, +$1.00.
- Watch: Prices read 46 s apart−0.670% vs +0.151%Part of this gap may be the market moving.
- Watch: Short leg is thinner$27K vs $359K OIInjective sets your exit cost. Check its book before closing.
- Note: No points program—Neither exchange runs points right now.
- OK: No KYC on either legPopdex No · Injective NoBoth exchanges let you trade without ID.
Profit calculator
both legs, in and outPosition, each legHold forOrdersPrice spreadFunding rate
Funding earned−0.0028%/8h × 21 periods−$5.91
Price spreadprices read too far apart to compare—
Slippage, 4 ordersdoesn’t fit the book at $10k—
Fee Popdex bp × 2 orders−$6.40
Fee Injective bp × 2 orders−$0.02
Net · 7 days · $10k—
doesn’t fit the books at $10kprice spread not counted: prices read too far apartCosts to cover—Break-even—
Slippage: Popdex: live order book, 15 min ago; Injective: live order book, 46 min agoCost to enter
taker + slippage from mid, one sideBUY · LONGPopdex1.086.8 bp−$738.9 bp−$389doesn’t fitdoesn’t fit
SELL · SHORTInjective38.88doesn’t fitdoesn’t fitdoesn’t fitdoesn’t fit
Closing costs about the same again.
| 09-29 19:30 | Vest Markets | Other | Trade $ORCL volatility with a Vest Capital funded account and access up to $25k in trading capital at: @VestExchange on X ↗ |
| 09-29 19:30 | Vest Markets | Other | Heading into the close, $ORCL is up around 4.2% with the launch of Fusion Claw, which adds 25 agentic applications. The company also introduced a native NetApp storage service on its cloud, with a full rollout planned within 12 months. The move puts the shares on pace to snap a four-day losing streak that had taken them about 11% lower. @VestExchange on X ↗ |
| 09-28 17:30 | Vest Markets | Other | Oracle's AI financing model is drawing fresh skepticism, with $ORCL down around 2.7% on the session. S&P lowered the credit rating to BBB-, the shares drew a Sell rating this morning, and five-year default swaps reached a record 227 basis points last week. The $18B of debt tied to Project Jupiter is quoted near 89 cents on the dollar, with about half of Oracle's $664B backlog tied to OpenAI. @VestExchange on X ↗ |
| 09-27 09:40 | Kalshi | Other | JUST IN: Oracle reportedly gave Larry Ellison and co-CEOs nearly $1 billion in stock options that "had no value" by fiscal year-end @Kalshi on X ↗ |
| 09-25 03:59 | Kalshi | Other | JUST IN: Oracle's "investment grade" bond closed at 8.10%, in line with B3/B- junk @Kalshi on X ↗ |
| 09-24 13:30 | Vest Markets | Other | $ORCL is down around 5.4% into the open, with a reported force majeure notice to its New Mexico data center developer. The notice goes to developer Blue Owl on Project Jupiter, seeking to defer payments if the 1,400-acre campus behind Oracle's OpenAI capacity deal slips past 2028. Trade $ORCL volatility with a Vest Capital funded account and access up to $25k in trading capital. @VestExchange on X ↗ |


Kalshi